Fifty medtech startups have participated in MassMEDIC’s Ignite since the program relaunched in 2019. The program matches startup founders with mentors in leadership positions at New England medtech organizations, makes introductions to investors and offers networking and experiential training to boost the region’s industry.
Get the full story at our sister site, Medical Design & Outsourcing.
Embr Labs makes the wearable Wave device for cooling relief from menopausal hot flashes. [Image courtesy of Embr Labs]
CoreMap’s $23 million in recently closed funding officially puts MassMEDIC’s Ignite alumni from the past three years over the $100 million mark, the medtech accelerator said.Fifty medtech startups have participated in MassMEDIC’s Ignite since the program relaunched in 2019. The program matches startup founders with mentors in leadership positions at New England medtech organizations, makes introductions to investors and offers networking and experiential training to boost the region’s industry.
“The experience of the program, the network of contacts and the MassMEDIC community of support continues to be of great value to us,” Sarah Kalil, co-founder and CEO of Burlington, Vermont–based CoreMap, said in a news release.
CoreMap leads all Ignite alumni …
The Burlington, Vermont–based company said it also closed on a $3 million Series A Milestone financing that was part of its $10.5 million Series A in September 2020. In addition, CoreMap won a National Science Foundation research grant that same month after participating as one of the startups in MassMEDIC’s IGNITE virtual accelerator when the program relaunched in 2019.
CoreMap said pre-clinical and clinical studies have successfully demonstrated the CoreMap System, which consists of the company’s high-resolution Invenio catheter and VidereX workstation.
“We have a catheter that will go inside the heart to record the electrical activity with high spatial resolution and create unambiguous electrograms. And that’s not …
Sarah Kalil is CEO and co-founder of CoreMap. [Photo courtesy of CoreMap]
CoreMap today announced it closed a $20 million Series B financing to accelerate the development of its cardiac arrhythmia diagnostic technology and launch pilot studies.The Burlington, Vermont–based company said it also closed on a $3 million Series A Milestone financing that was part of its $10.5 million Series A in September 2020. In addition, CoreMap won a National Science Foundation research grant that same month after participating as one of the startups in MassMEDIC’s IGNITE virtual accelerator when the program relaunched in 2019.
CoreMap said pre-clinical and clinical studies have successfully demonstrated the CoreMap System, which consists of the company’s high-resolution Invenio catheter and VidereX workstation.
“We have a catheter that will go inside the heart to record the electrical activity with hi…